scholarly journals The World Health Organization Global Action Plan for antimicrobial resistance

2015 ◽  
Vol 105 (5) ◽  
pp. 325 ◽  
Author(s):  
Marc Mendelson ◽  
Malebona Precious Matsoso
2020 ◽  
Author(s):  
Yuko Okemoto-Nakamura ◽  
Kenji Someya ◽  
Toshiyuki Yamaji ◽  
Kyoko Saito ◽  
Makoto Takeda ◽  
...  

AbstractPolio or poliomyelitis is a disabling and life-threatening disease caused by poliovirus (PV). As a consequence of global polio vaccination efforts, wild PV serotype 2 has been eradicated, and wild PV serotypes 1- and 3-transmitted cases have been largely eliminated except for in limited regions around the world. However, vaccine-derived PV, pathogenically reverted live PV vaccine strains in vaccinated humans, has become a serious issue. For the global eradication of polio, the World Health Organization is conducting the third edition of the Global Action Plan, which is requesting stringent control of potentially PV-infected materials. To facilitate the mission, we generated a PV-nonsusceptible Vero cell subline, which may serve as an ideal replacement of standard Vero cells to isolate emerging/re-emerging viruses without the risk of generating PV-infected materials.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yuko Okemoto-Nakamura ◽  
Kenji Someya ◽  
Toshiyuki Yamaji ◽  
Kyoko Saito ◽  
Makoto Takeda ◽  
...  

AbstractPolio or poliomyelitis is a disabling and life-threatening disease caused by poliovirus (PV). As a consequence of global polio vaccination efforts, wild PV serotypes 2 and 3 have been eradicated around the world, and wild PV serotype 1-transmitted cases have been largely eliminated except for limited regions. However, vaccine-derived PV, pathogenically reverted live PV vaccine strains, has become a serious issue. For the global eradication of polio, the World Health Organization is conducting the third edition of the Global Action Plan, which is requesting stringent control of potentially PV-infected materials. To facilitate the mission, we generated a PV-nonsusceptible Vero cell subline, which may serve as an ideal replacement of standard Vero cells to isolate emerging/re-emerging viruses without the risk of generating PV-infected materials.


2021 ◽  
Vol 26 (1) ◽  
Author(s):  
H. Amini ◽  
S. Habibi ◽  
A. H. Islamoglu ◽  
E. Isanejad ◽  
C. Uz ◽  
...  

AbstractTo prevent and reduce inactivity, the World Health Organization (WHO) designed a global plan called Global Action Plan on Physical Activity 2018–2030 (GAPPA) in 2017. In this plan and according to the state of physical activity in 2016, actions and goals were set. However, the world is facing a COVID-19 pandemic, which has affected various aspects of lifestyle, including physical activity. Some studies have shown that physical activity reduced during the pandemic. For this reason, the WHO should review the GAPPA and update goals and actions according to the state of physical activity in 2020.


2015 ◽  
Vol 43 (S3) ◽  
pp. 68-73 ◽  
Author(s):  
Asha Behdinan ◽  
Steven J. Hoffman ◽  
Mark Pearcey

This article assesses which policies for addressing antibiotic resistance (ABR) as part of a multi-pronged approach would benefit from legalization through an international legal agreement. Ten candidate policies were identified based on a review of existing literature, especially The Lancet Series on Antimicrobial Resistance (AMR), The Lancet Infectious Diseases Commission on AMR, and the World Health Organization (WHO) Global Action Plan for AMR. These policies were then grouped under the headings of access, conservation, and innovation.Each of the ten policies were assessed using four criteria developed by Hoffman, Røttingen, and Frenk to help consider why their legalization may be helpful, necessary and/or justified. These criteria are: (1) the problem has a significant transnational dimension; (2) the goal justifies the coercive nature of law; (3) the outcome is likely to be beneficial; and (4) legalization represents the best commitment mechanism among competing alternatives.


Epilepsia ◽  
2021 ◽  
Author(s):  
Alla Guekht ◽  
Martin Brodie ◽  
Mary Secco ◽  
Shichuo Li ◽  
Nancy Volkers ◽  
...  

2018 ◽  

En el informe de la OMS sobre la farmacorresistencia del VIH del 2017 se pone de manifiesto el aumento constante de la prevalencia de la FRVIH desde el 2001 en las personas que inician un tratamiento antirretroviral de primera línea, sobre todo en África oriental y meridional. La prevalencia de la FRVIH en las personas que iniciaron un tratamiento antiretroviral de primera línea (farmacorresistencia previa al tratamiento o FRP) fue del 6,8% en el 2010, y los cálculos basados en encuestas recientes representativas a nivel nacional indicant niveles de FRP situados por encima del 10% para los fármacos ARV de primera línea recomendados por la OMS que son ampliamente utilizados en muchos países […] Este plan de acción mundial se elaboró con la participación plena de los asociados clave (por ejemplo, los CDC, el Fondo Mundial y el PEPFAR). Proporciona a los países y a los asociados nacionales e internacionales un marco de referencia que, cuando se aplique de manera conjunta entre el 2017 y el 2021, contribuirá al logro de las metas mundiales 90-90-90 de acción acelerada para el 2020 (un 90% de todas las personas con infección por el VIH conocerán su estado con respecto a dicha infección, un 90% de todas las personas con diagnóstico de infección por el VIH recibirán TAR, y un 90% de todas las personas que tengan acceso al TAR alcanzarán la supresión de la carga viral), así como a poner fin a la epidemia del sida como amenaza de salud pública para el 2030. Versión oficial en español de la obra original en inglés Global action plan on HIV drug resistance 2017-2021 © World Health Organization 2017 ISBN: 978-92-4-151284-8


2019 ◽  

El nuevo plan de acción mundial de la OMS para la promoción de la actividad física responde a las solicitudes de los países de recibir orientación actualizada y un marco de medidas normativas efectivas y viables destinadas a aumentar la actividad física en todos los niveles. También responde a las solicitudes de que se establezca un liderazgo a nivel mundial en este tema, así como una mayor coordinación regional y nacional, y a la necesidad de una respuesta que abarque a toda la Sociedad para lograr un cambio de paradigma apoyando y valorando que todas las personas se mantengan activas de manera regular, de acuerdo con su capacidad y a lo largo de toda la vida. El presente plan de acción se ha elaborado mediante un proceso de consulta mundial en que han participado gobiernos y partes interesadas clave de múltiples sectores, entre ellos los de salud, deportes, transporte, diseño urbano, sociedad civil, el sector académico y el sector privado. Versión oficial en español de la obra original en inglés: Global action plan on physical activity 2018-2030: more active people for a healthier world. © World Health Organization 2018. ISBN: 978-92-4-151418-7.


2020 ◽  
Vol 16 (1) ◽  
Author(s):  
Louise Munkholm ◽  
Olivier Rubin

Abstract Background Antimicrobial resistance (AMR) is a growing problem worldwide in need of global coordinated action. With the endorsement of the Global Action Plan (GAP) on AMR in 2015, the 194 member states of the World Health Organization committed to integrating the five objectives and corresponding actions of the GAP into national action plans (NAPs) on AMR. The article analyzes patterns of alignment between existing NAPs and the GAP, bringing to the fore new methodologies for exploring the relationship between globally driven health policies and activities at the national level, taking income, geography and governance factors into account. Methods The article investigates the global governance of AMR. Concretely, two proxies are devised to measure vertical and horizontal alignment between the GAP and existing NAPs: (i) a syntactic indicator measuring the degree of verbatim overlap between the GAP and the NAPs; and (ii) a content indicator measuring the extent to which the objectives and corresponding actions outlined in the GAP are addressed in the NAPs. Vertical alignment is measured by the extent to which each NAP overlaps with the GAP. Horizontal alignment is explored by measuring the degree to which NAPs overlap with other NAPs across regions and income groups. In addition, NAP implementation is explored using the Global Database for Antimicrobial Resistance Country Self-Assessment. Findings We find strong evidence of vertical alignment, particularly among low-income countries and lower-middle-income countries but weaker evidence of horizontal alignment within regions. In general, we find the NAPs in our sample to be mostly aligned with the GAP’s five overarching objectives while only moderately aligned with the recommended corresponding actions. Furthermore, we see several cases of what can be termed ‘isomorphic mimicry’, characterized by strong alignment in the policies outlined but much lower levels of alignment in terms of actual implemented policies. Conclusion To strengthen the alignment of national AMR policies, we recommend global governance initiatives based on individualized responsibilities some of which should be legally binding. Our study provides limited evidence of horizontal alignment within regions, which implies that regional governance institutions (e.g., WHO regional offices) should primarily act as mediators between global and local demands to strengthen a global governance regime that minimizes policy fragmentation and mimicry behavior across member states.


Sign in / Sign up

Export Citation Format

Share Document